Cytune Pharma Secures EUR 6M in Financing to Advance Lead Immuno-Oncology Program to Phase I
NANTES, FRANCE -- (Marketwired) -- 06/29/16 -- Cytune Pharma SAS, a French biotechnology company focused on developing novel immunotherapies for the treatment of cancer, announced the closing of a EUR 6M financing round from existing investors. Funds will …